Natacha Lobos

  • Special Engineer; Bsc, Msc
  • +47 22 78 23 18

Barnekreftforeningen (PERCAP)


2021-2022 – MSc in Molecular Biology and Biochemistry – UiO, Oslo | Main studies: Molecular Biology, Cancer Biology and Immunology.

2014-2019 – BSc in Biochemistry and Biomedicine Sciences – University of Valencia, Spain | Main studies: Biochemistry, Molecular Biology and Genetics.

Research interests/projects:

  • Development of novel cellular therapies (CARs, engineered TCRs)
  • Cancer Immunotherapy

Work Experience:

2023-Present – Special Engineer, Dept. of Cellular Therapy, OUS Radiumhospitalet, Oslo, Norway

2022-2023 – Researcher, Dept. of Biosciences, UiO, Oslo, Norway

2022 – Visiting Researcher, Dept. of Immunology, Infectiology and Hematology, Institute Necker Enfants Malades, Paris, France

2020-2022 – Principal Engineer, Dept. of Biosciences, UiO, Oslo, Norway

2017-2018 – Internship, Dept. of Biosciences, UiO, Oslo, Norway

2017 – Internship, Principe Felipe Research Center Foundation, Valencia, Spain

Grant and awards:

2020-2023 – Forskingsrådet Research Fellowship

2022 – The Count Hjelmstjerne-Rosencroneske Foundation Travel Grant

2017-2018 – Erasmus+ Studying abroad Grant


Lobos Patorniti N, Zulkefli KL, McAdam ME, Vargas P, Bakke O and Progida C (2023) Rai14 is a novel interactor of Invariant chain that regulates macropinocytosis. Front. Immunol. 14:1182180. doi: 10.3389/fimmu.2023.1182180


Page visits: 157